Corporate News     08-Jun-23
Zydus receives USFDA approval for Esomeprazole Magnesium for Delayed-Release Oral Suspension
Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) for Esomeprazole Magnesium for Delayed-Release Oral Suspension, 20 mg and 40 mg (USRLD: Nexium Delayed-Release for Oral Suspension, 20 mg and 40 mg).

Esomeprazole is used to treat certain stomach and esophagus problems (such as acid reflux and ulcer). It works by decreasing the amount of acid your stomach makes. It relieves symptoms such as heartburn, difficulty swallowing, and cough. This medication helps heal acid damage to the stomach and esophagus, helps prevent ulcers and is expected to help prevent cancer of the esophagus. Esomeprazole belongs to a class of drugs known as proton pump inhibitors (PPIs). The product will be manufactured at the group's formulation manufacturing facility in Moraiya, Ahmedabad (India).

Esomeprazole Magnesium for Delayed-Release Oral Suspension, 20 mg and 40 mg had annual sales of USD 42 mn in the United States (IQVIA MAT April 2023).

Previous News
  Zydus receives USFDA tentative approval for Azilsartan Medoxomil and Chlorthalidone Tablets
 ( Corporate News - 14-Jun-24   13:42 )
  Zydus Lifesciences receives USFDA approval for Isosorbide Mononitrate ER Tablets
 ( Corporate News - 16-Feb-24   14:31 )
  Zydus Life gains on USFDA nod for prostatic hyperplasia drug
 ( Hot Pursuit - 18-Mar-24   09:40 )
  Zydus Lifesciences Ltd spurts 1.16%, rises for third straight session
 ( Hot Pursuit - 26-Feb-24   13:05 )
  Zydus enters into licensing and supply agreement with Synthon BV for Palbociclib Tablets
 ( Corporate News - 19-Jan-24   09:15 )
  Zydus Life receives USFDA approval for Zinc Sulfate Injection
 ( Hot Pursuit - 24-Aug-23   11:50 )
  Zydus Life hits record high on USFDA nod for chest pain prevention drug
 ( Hot Pursuit - 16-Feb-24   16:53 )
  Zydus Life gets US FDA nod for anti-cancer medication Cyclophosphamide
 ( Hot Pursuit - 14-Dec-23   14:31 )
  Zydus receives USFDA final approval for Cyclophosphamide Capsules
 ( Corporate News - 14-Dec-23   18:57 )
  Zydus Lifesciences Ltd soars 0.37%, rises for fifth straight session
 ( Hot Pursuit - 14-Feb-24   13:00 )
  Board of Zydus Lifesciences recommends Final Dividend
 ( Corporate News - 19-May-23   16:35 )
Other Stories
  Time Technoplast repays commercial paper
  03-Jul-24   18:31
  Board of Aditya Vision approves stock split and listing of share on NSE
  03-Jul-24   18:24
  Pricol director resigns
  03-Jul-24   18:21
  Board of VMS Industries recommends first interim dividend
  03-Jul-24   17:49
  Lakshmi Machine Works to declare Quarterly Result
  03-Jul-24   17:44
  Modison to convene AGM
  03-Jul-24   17:43
  Sybly Industries to discuss results
  03-Jul-24   17:43
  Akme Fintrade (India) to announce Quarterly Result
  03-Jul-24   17:43
  Ponni Sugars (Erode) to hold board meeting
  03-Jul-24   17:43
  Aditya Vision to conduct AGM
  03-Jul-24   17:43
Back Top